SSX7 antibody (Middle Region)

Catalog No. ABIN503245

This Rabbit Polyclonal antibody specifically detects SSX7 in WB. It exhibits reactivity toward Human.

Quick Overview for SSX7 antibody (Middle Region) (ABIN503245)

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SSX7 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-SSX7 Antibody

Binding Specificity: Middle Region

Sequence: IFPKIMPKKP AEEGNDSKGV PEASGSQNDG KHLCPPGKPS TSEKINKTSG

Predicted Reactivity: Human: 100%

Characteristics: This is a rabbit polyclonal antibody against SSX7. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human SSX7

Application Details

Application Notes: Optimal working dilutions should be determined experimentally by the investigator.

Comment:

Antigen size: 188 AA

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze-thaw cycles.

Storage: -20 °C

Storage Comment: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Target Details for SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Alternative Name: SSX7

Background: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation.
Protein Size: 188

Molecular Weight: 21 kDa

Gene ID: 280658

NCBI Accession: NM_173358, NP_775494

UniProt: Q7RTT5